Drug Type Fecal microbiota transplantation |
Synonyms MGT-006 |
Target- |
Action modulators |
Mechanism Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Phase 2 | United States | 27 May 2026 | |
| Colitis, Ulcerative | Phase 2 | Japan | 27 May 2026 |





